PT  - JOURNAL ARTICLE
AU  - Chiu, I-Min
AU  - Chen, Tien-Yu
AU  - Zheng, You-Cheng
AU  - Lin, Xin-Hong
AU  - Cheng, Fu-Jen
AU  - Ouyang, David
AU  - Cheng, Chi-Yung
TI  - Prospective Clinical Evaluation of a Deep Learning Algorithm for Guided Point-of-Care Ultrasonography Screening of Abdominal Aortic Aneurysms
AID  - 10.1101/2024.02.06.24302423
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.02.06.24302423
4099  - http://medrxiv.org/content/early/2024/02/08/2024.02.06.24302423.short
4100  - http://medrxiv.org/content/early/2024/02/08/2024.02.06.24302423.full
AB  - Background Abdominal Aortic Aneurysm (AAA) is a critical condition that can lead to fatal consequences if not detected and treated early. Despite the high prevalence in smokers and guideline recommendation for screening, AAA often remains undetected due to availability of diagnostic ultrasound examinations. This prospective clinical trial aimed to investigate the use of a Deep Learning (DL) algorithm to guide AAA screening.Methods This prospective, comparative diagnostic study was conducted at the Kaohsiung Chang Gung Memorial Hospital. We developed and deployed an object detection-based DL algorithm providing real-time guidance for novice users performing AAA screening using point of care ultrasound. 10 registered nurses with no prior ultrasonography experience were recruited and performed at least 15 scans on patients over 65 years old to acquire abdominal aorta videos. These scans were compared with those of physicians using the same ultrasound hardware but without DL guidance.Results A total of 184 patients (median [IQR] age of 72 [67-79], and 105 (57.1%) male) completed this study. The DL-guided novices achieved adequate scan quality in 87.5% (95% CI: 82.7 - 92.3%) of patients, comparable to the 91.3% (95% CI: 87.2-95.4%) rate of physician scans (p=0.310). This performance did not vary by BMI. The DL model predicted AAA with an AUC of 0.975, showing 100% sensitivity and 94.3% specificity. The DL model predicted the maximal width of abdominal aorta with mean absolute error of 2.8mm compared to physician measurements. 3 AAA with maximal width of aorta > 3cm were found in this study cohort.Conclusion DL-guided POCUS is an effective tool for AAA screening, providing comparable performance to experienced physicians. The use of this DL system could democratize AAA screening and improve access, thereby aiding in early disease detection and treatment.What is NewOur study presents a deep learning (DL) guidance system that enables novice users to perform Abdominal Aortic Aneurysm (AAA) screening with POCUS, yielding image quality comparable to experienced physicians.The DL algorithm accurately identifies AAA from scans conducted by novice users, maintains consistent performance across patients with varying BMIs, and demonstrates increased scan efficiency with repeated use.Clinical ImplicationsDL-guided POCUS can potentially expand AAA screening capabilities to non-specialist settings and increase throughput for screening at risk individuals.The implementation of our DL model for AAA screening could enhance early detection, particularly in underserved areas, but also optimize clinical workflows by decreasing diagnostic wait times and increasing ultrasound utilization efficiency.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by National Science and Technology CouncilAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the institutional review board at the Kaohsiung Chang Gung Memorial Hospital (IRB number: 202102311B0). Written consent was obtained from each participant.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesNot available